Haemoglobin disorders in Australia: where are we now and where will we be in the future? - Wikidata - wikimedia - TriplyDB

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

http://www.wikidata.org/entity/Q30251663

about

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

http://www.wikidata.org/entity/Q30251663

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

@ast

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

@en

type

label

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

@ast

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

@en

prefLabel

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

@ast

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

@en

P1433

Q30251663-46EDBBAD-C0CB-4C2F-983C-74E4881394D6

P1476

Q30251663-D4455473-D5E9-43AA-B807-64F3C41F1153

P2093

Q30251663-1BC379FB-3A56-4143-ADE9-A679B1542A0A

Q30251663-36AA2768-980E-4F74-B4B1-29F834FE3023

Q30251663-E5AADD84-8286-4930-978E-5264886EB85C

Q30251663-FFE5301C-0AA6-462C-8A6B-45F0664EF4D0

P2860

Q30251663-04AC329A-BA15-42B5-A1D7-8AF1E7A88B25

Q30251663-15DBAE34-AC0E-4BC7-9146-E8F8B007D015

Q30251663-257546FF-6234-46B3-9F7B-FF76267E5041

Q30251663-33467F4B-0A25-4919-A95B-D4B486239C2F

Q30251663-3950457B-0AF7-4995-9418-E8AEC7B26512

Q30251663-396474C2-224D-4CF7-863F-541447FC3122

Q30251663-402B8341-613D-4620-910C-C969BCD823E5

Q30251663-402C7385-8580-4E8E-A7BF-6D0026BC5AC0

Q30251663-4FFDAF76-A8D3-45DB-8B81-F6019E74B3B8

Q30251663-5018C683-6CE8-4A44-89A5-BDAD5623DFC2

P304

Q30251663-274F4169-A846-4B55-862F-9660FB5D5C1D

P31

Q30251663-EC2BEF0D-9586-43A1-AAD4-0D2DE4149718

P356

Q30251663-49C35D02-8C43-4C02-9D77-F39E503D5920

P433

Q30251663-D0772F16-EBC6-4A41-BB44-EF97B5EBE1B5

P478

Q30251663-7ACE8D52-F5D4-494D-84F0-6779D88CA253

P50

Q30251663-D6D1959F-CF2E-4989-BCC5-120F0FAA2585

P577

Q30251663-4A99C1C7-3E66-45F9-A076-1BD84344FE72

P698

Q30251663-3558E78F-7912-41C6-9A6D-BC67D269C356

P921

Q30251663-A59BE404-5FB5-47C3-A6E9-60E1A936C7BF

P356

P1433

Internal Medicine Journal

P1476

Haemoglobin disorders in Australia: where are we now and where will we be in the future?

@en

P2093

D Bowden

http://www.w3.org/2001/XMLSchema#string

G Crighton

http://www.w3.org/2001/XMLSchema#string

P J Ho

http://www.w3.org/2001/XMLSchema#string

R Scarborough

http://www.w3.org/2001/XMLSchema#string

P2860

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.

Improved survival of children and adolescents with sickle cell disease.

Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.

Hemoglobin H disease: not necessarily a benign disorder.

Health-related quality of life in children and adolescents with sickle cell disease

Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia?

P304

770-779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IMJ.13084

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27040044

http://www.w3.org/2001/XMLSchema#string

P921